The TIMI risk score for STEMI predicts in-hospital mortality and adverse events in patients without cardiogenic shock undergoing primary angioplasty

González-Pacheco, Héctor; Arias-Mendoza, Alexandra; Álvarez-Sangabriel, Amada; Juárez-Herrera, Úrsulo; Damas, Félix; Eid-Lidt, Guering; Azar-Manzur, Francisco; Martínez-Sánchez, Carlos.
Arch. cardiol. Méx ; 82(1): 7-13, ene.-mar. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-657944

Documentos relacionados

  1. Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
  2. Myocardial infarction cell by cell.
  3. Association between albumin corrected anion gap and 30-day all-cause mortality of critically ill patients with acute myocardial infarction: a retrospective analysis based on the MIMIC-IV database.
  4. [The application of the David back concept mechanotherapy in patients survived after myocardium infarction].
  5. [A He(art) museum for an existential rebirth after a myocardial infarction].
  6. Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
  7. Lipoprotein (a) and myocardial infarction: impact on long-term mortality.
  8. Prognostic Value of Natriuretic Peptide Levels and In-Hospital Heart Failure Events in Patients With Acute Myocardial Infarction.
  9. Optimizing Blood Transfusion in Patients with Acute Myocardial Infarction.
  10. Integrative Analysis of N6-methyladenosine RNA modifications related genes and their Influences on Immunoreaction or fibrosis in myocardial infarction.